Welcome to the DZIF -

the German Center for Infection Research

Research Areas

Gastrointestinal Infections

Hepatitis

HIV

Infections of the immunocompromised Host

Healthcare-associated and Antibiotic-resistant bacterial Infections

Malaria

Emerging Infections

Novel Antibiotics

Tuberculosis

News

The Epstein-Barr virus (EBV) prevents infected cells from being attacked by the immune system
© Georg Bornkamm/Helmholtz Zentrum München

New guideline for virus infections in transplant patients

Spitzmaus
© Ulrike Rosenfeld

Hepatitis B: Unusual virus discovered in shrews

The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of the disease. International research teams were able to demonstrate
Dirk Busch and his study team
© K. Schober/TUM

Successful T cell engineering with gene scissors

The idea of genetically modifying a patient’s own immune cells and deploying them against infections and tumors has been around since the 1980s. But to this day modified T cells are still not as
Staphylococcus aureus (magenta-colored)
© National Institute of Allergy and Infectious

Natural antibiotic’s multi-level attack strategy helps prevent resistance

The natural antibiotic Lugdunin, discovered three years ago by Tübingen DZIF researchers, attacks pathogenic bacteria in several different ways simultaneously and also interacts with the defense
Hepatitis B virions (orange coloured)
© CDC/Dr. Erskine Palmer

Checkmate for hepatitis B viruses in the liver

Researchers have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model. The team showed in its publication, that T-cell therapy can provide a
All news

Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists

Follow us on:

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Find Media Content

Research in Focus

Hamburg - Lübeck - Borstel - Riems

Clinical Tuberculosis Centre

The Clinical Tuberculosis Centre provides the expertise and infrastructure for the optimisation, prevention, diagnosis and treatment of tuberculosis (TB) as well as for translating research results into clinical practice. The main objectives of the Clinical Tuberculosis Centre include coordinating clinical research activities involving the DZIF TB cohort. This cohort includes [...]

Read more
Bonn - Cologne | Hamburg - Lübeck - Borstel - Riems | Munich | Tübingen

Neglected Tropical Diseases

Currently, approximately one billion people worldwide are at risk of developing an inability to work or blindness, becoming maimed or dying due to neglected tropical diseases (NTD). NTDs include river blindness, dengue fever, sleeping sickness, snakebites and leprosy, only to name a few known examples of this diverse group of [...]

Read more
Hanover - Brunswick

Preclinical development of Amidochelocardins

The challenge of antibiotic drug development today is the discovery and optimisation of novel bioactive compounds that do not show cross-resistances with clinically applied antibiotics, ideally due to a novel mode of action (MoA) which adresses unexploited microbial targets. In the case of chelocardin, this antibiotic substance was identified several [...]

Read more
Tübingen

New strategies for specific eradication of Staphylococcus aureus

In this project, the scientists develop genetically engineered phage lysins and specific bacteriocins for the elimination of hospital germs such as Staphylococcus aureus, they clarify mechanisms of potential resistance mechanisms, and they analyse whether broad-spectrum or specifically acting agents have a more effective and lasting effect on colonization by S. [...]

Read more

Our Partner Sites

Munich Tuebingen Heidelberg Gießen – Marburg – Langen Bonn – Cologne Hanover – Brunswick Hamburg – Lubeck Borstel – Riems
53
Databases- & Biobanks